Yocca FD - Search Results

1

The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release.

Aihara K, Shimada J, Miwa T, Tottori K, Burris KD, Yocca FD, Horie M, Kikuchi T. Aihara K, et al. Among authors: yocca fd. Brain Res. 2004 Apr 2;1003(1-2):9-17. doi: 10.1016/j.brainres.2003.09.082. Brain Res. 2004. PMID: 15019558

2

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.

Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB. Burris KD, et al. Among authors: yocca fd. J Pharmacol Exp Ther. 2002 Jul;302(1):381-9. doi: 10.1124/jpet.102.033175. J Pharmacol Exp Ther. 2002. PMID: 12065741

3

Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.

Stark AD, Jordan S, Allers KA, Bertekap RL, Chen R, Mistry Kannan T, Molski TF, Yocca FD, Sharp T, Kikuchi T, Burris KD. Stark AD, et al. Among authors: yocca fd. Psychopharmacology (Berl). 2007 Feb;190(3):373-82. doi: 10.1007/s00213-006-0621-y. Epub 2006 Nov 25. Psychopharmacology (Berl). 2007. PMID: 17242925

4

Synthesis and biological characterization of alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol and analogues as potential atypical antipsychotic agents.

Yevich JP, New JS, Lobeck WG, Dextraze P, Bernstein E, Taylor DP, Yocca FD, Eison MS, Temple DL Jr. Yevich JP, et al. Among authors: yocca fd. J Med Chem. 1992 Nov 27;35(24):4516-25. doi: 10.1021/jm00102a002. J Med Chem. 1992. PMID: 1361578

5

5-HT receptors linked to adenylyl cyclase activity in mammalian brain.

Yocca FD, Maayani S. Yocca FD, et al. Ann N Y Acad Sci. 1990;600:212-23. doi: 10.1111/j.1749-6632.1990.tb16884.x. Ann N Y Acad Sci. 1990. PMID: 2123617 Review. No abstract available.

6

5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus.

Matos FF, Korpinen C, Yocca FD. Matos FF, et al. Among authors: yocca fd. Eur J Pharmacol. 1996 Dec 12;317(1):49-54. doi: 10.1016/s0014-2999(96)00699-1. Eur J Pharmacol. 1996. PMID: 8982718

7

Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.

Yocca FD, Iben L, Meller E. Yocca FD, et al. Mol Pharmacol. 1992 Jun;41(6):1066-72. Mol Pharmacol. 1992. PMID: 1352034

8

Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes.

Gribkoff VK, Pieschl RL, Wisialowski TA, van den Pol AN, Yocca FD. Gribkoff VK, et al. Among authors: yocca fd. J Neurosci. 1998 Apr 15;18(8):3014-22. doi: 10.1523/JNEUROSCI.18-08-03014.1998. J Neurosci. 1998. PMID: 9526018 Free PMC article.

9

A role for sigma binding in the antipsychotic profile of BMY 14802?

Taylor DP, Eison MS, Moon SL, Schlemmer RF Jr, Shukla UA, VanderMaelen CP, Yocca FD, Gallant DJ, Behling SH, Boissard CG, et al. Taylor DP, et al. Among authors: yocca fd. NIDA Res Monogr. 1993;133:125-57. NIDA Res Monogr. 1993. PMID: 8232511 Review.

10

Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatment.

Yocca FD, Eison AS, Hyslop DK, Ryan E, Taylor DP, Gianutsos G. Yocca FD, et al. Life Sci. 1991;49(24):1777-85. doi: 10.1016/0024-3205(91)90478-t. Life Sci. 1991. PMID: 1682780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page